MED
Price
$12.85
Change
+$0.11 (+0.86%)
Updated
Aug 8 closing price
Capitalization
141.24M
93 days until earnings call
TOUR
Price
$0.76
Change
-$0.02 (-2.56%)
Updated
Aug 8 closing price
Capitalization
87.75M
6 days until earnings call
Interact to see
Advertisement

MED vs TOUR

Header iconMED vs TOUR Comparison
Open Charts MED vs TOURBanner chart's image
Medifast
Price$12.85
Change+$0.11 (+0.86%)
Volume$157.56K
Capitalization141.24M
Tuniu
Price$0.76
Change-$0.02 (-2.56%)
Volume$197.93K
Capitalization87.75M
MED vs TOUR Comparison Chart in %
Loading...
MED
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TOUR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MED vs. TOUR commentary
Aug 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MED is a Hold and TOUR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 10, 2025
Stock price -- (MED: $12.85 vs. TOUR: $0.76)
Brand notoriety: MED and TOUR are both not notable
Current volume relative to the 65-day Moving Average: MED: 66% vs. TOUR: 92%
Market capitalization -- MED: $141.24M vs. TOUR: $87.75M

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MED’s FA Score shows that 2 FA rating(s) are green whileTOUR’s FA Score has 1 green FA rating(s).

  • MED’s FA Score: 2 green, 3 red.
  • TOUR’s FA Score: 1 green, 4 red.
According to our system of comparison, MED is a better buy in the long-term than TOUR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MED’s TA Score shows that 3 TA indicator(s) are bullish while TOUR’s TA Score has 4 bullish TA indicator(s).

  • MED’s TA Score: 3 bullish, 6 bearish.
  • TOUR’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, TOUR is a better buy in the short-term than MED.

Price Growth

MED (@Personnel Services) experienced а -6.55% price change this week, while TOUR (@Consumer Sundries) price change was -2.54% for the same time period.

The average weekly price growth across all stocks in the @Personnel Services industry was +1.95%. For the same industry, the average monthly price growth was -5.40%, and the average quarterly price growth was +163.25%.

Reported Earning Dates

MED is expected to report earnings on Nov 10, 2025.

TOUR is expected to report earnings on Aug 15, 2025.

Industries' Descriptions

@Personnel Services (+1.95% weekly)

Personnel Services comprise companies that provide staffing and human resources management solutions for businesses. Each company might be involved in one or more types of recruitment or employee solutions such as permanent or temporary staffing, career consulting, outsourcing, administrative services and many more. Some personnel services companies cater to large businesses, while some specialize in providing services to small/medium-sized organizations. These specialized services potentially expedite the process of getting the ‘right’ candidates and/or training them to meet the requirements of a business process. Some of the companies also cover other critical areas like internal auditing for a company. Robert Half International Inc., ManpowerGroup Inc. and Insperity, Inc. are examples of companies in the personnel services industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MED($141M) has a higher market cap than TOUR($87.8M). MED has higher P/E ratio than TOUR: MED (38.94) vs TOUR (11.32). TOUR YTD gains are higher at: -23.259 vs. MED (-27.072). TOUR has higher annual earnings (EBITDA): 58.5M vs. MED (6.4M). TOUR has more cash in the bank: 1.04B vs. MED (165M). TOUR has less debt than MED: TOUR (4.68M) vs MED (14.6M). MED (543M) and TOUR (523M) have equivalent revenues.
MEDTOURMED / TOUR
Capitalization141M87.8M161%
EBITDA6.4M58.5M11%
Gain YTD-27.072-23.259116%
P/E Ratio38.9411.32344%
Revenue543M523M104%
Total Cash165M1.04B16%
Total Debt14.6M4.68M312%
FUNDAMENTALS RATINGS
MED vs TOUR: Fundamental Ratings
MED
TOUR
OUTLOOK RATING
1..100
5060
VALUATION
overvalued / fair valued / undervalued
1..100
2
Undervalued
12
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9282
PRICE GROWTH RATING
1..100
8381
P/E GROWTH RATING
1..100
365
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MED's Valuation (2) in the Specialty Stores industry is in the same range as TOUR (12) in the Other Consumer Services industry. This means that MED’s stock grew similarly to TOUR’s over the last 12 months.

MED's Profit vs Risk Rating (100) in the Specialty Stores industry is in the same range as TOUR (100) in the Other Consumer Services industry. This means that MED’s stock grew similarly to TOUR’s over the last 12 months.

TOUR's SMR Rating (82) in the Other Consumer Services industry is in the same range as MED (92) in the Specialty Stores industry. This means that TOUR’s stock grew similarly to MED’s over the last 12 months.

TOUR's Price Growth Rating (81) in the Other Consumer Services industry is in the same range as MED (83) in the Specialty Stores industry. This means that TOUR’s stock grew similarly to MED’s over the last 12 months.

MED's P/E Growth Rating (3) in the Specialty Stores industry is somewhat better than the same rating for TOUR (65) in the Other Consumer Services industry. This means that MED’s stock grew somewhat faster than TOUR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MEDTOUR
RSI
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
72%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 19 days ago
64%
Bullish Trend 19 days ago
78%
Declines
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 2 days ago
86%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
85%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
MED
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TOUR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMNF8.680.54
+6.63%
Armanino Foods of Distinction, Inc.
ASMLF718.985.12
+0.72%
ASML Holding N.V.
CFTLF0.72N/A
N/A
Chinasoft International Ltd.
TLSNF3.72N/A
N/A
Telia Company AB
MDXXF0.10N/A
N/A
PharmAla Biotech Holdings Inc.

MED and

Correlation & Price change

A.I.dvisor indicates that over the last year, MED has been loosely correlated with EXPE. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if MED jumps, then EXPE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MED
1D Price
Change %
MED100%
+0.86%
EXPE - MED
36%
Loosely correlated
+4.08%
CSV - MED
31%
Poorly correlated
+0.44%
TNL - MED
23%
Poorly correlated
-0.36%
MCW - MED
23%
Poorly correlated
-0.35%
HRB - MED
22%
Poorly correlated
+0.36%
More

TOUR and

Correlation & Price change

A.I.dvisor indicates that over the last year, TOUR has been loosely correlated with SDRMF. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if TOUR jumps, then SDRMF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TOUR
1D Price
Change %
TOUR100%
-3.00%
SDRMF - TOUR
34%
Loosely correlated
N/A
TCOM - TOUR
29%
Poorly correlated
-5.41%
MED - TOUR
22%
Poorly correlated
+0.86%
CCL - TOUR
21%
Poorly correlated
-2.21%
MMYT - TOUR
20%
Poorly correlated
-1.07%
More